Abstract
Purpose
To provide an update of putative auto-antigens identified and proposed to be involved in human ovarian autoimmunity.
Methods
Review of literature pertaining to ovarian auto-antigens / proteins identified with various immunological tools using sera of infertile women as a probe for investigation.
Results
An overview of autoimmune targets known till date in the study of human ovarian autoimmunity.
Conclusions
Anti-ovarian antibodies (AOA) to multiple components and compartments of the ovary are present in the sera of infertile women. Researchers propose that these AOA may be responsible for ovarian failures and therefore render women to be infertile. Evaluation of AOA can be effective as a prognostic factor in the treatment of infertile patients and for the IVF-ET program.
References
Luborsky J. Ovarian autoimmune disease and ovarian autoantibodies. J Women’s Health Gend Based Med. 2002;11:585–99.
Nelson LM. Primary ovarian insufficiency. N Engl J Med. 2009;360:606–14.
Albright F, Smith PH, Fraser R. A syndrome characterized by primary ovarian insufficiency and decreased stature. Am J Med Sci. 1942;204:625–48.
Anasti JN. Premature ovarian failure: an update. Fertil Steril. 1998;70(1):1–15.
Luborsky JL, Visintin I, Boyers S, Asari T, Caldwell B, DeCherney A. Ovarian antibodies detected by immobilized antigen immunoassay in patients with premature ovarian failure. J Clin Endocrinol Metab. 1990;70:69–75.
Wheatcroft NJ, Toogood AA, Li TC, Cooke D, Weetman AP. Detection of antibodies to ovarian antigens in women with premature ovarian failure. Clin Exp Immunol. 1994;96:122–8.
Fénichel P, Sosset C, Barbarino-Monnier P, Gobert B, Hiéronimus S, Béné MC, et al. Prevalence, specificity and significance of ovarian antibodies during spontaneous premature ovarian failure. Hum Reprod. 1997;12:2623–8.
Pires ES, Parte PP, Meherji PK, Khan SA, Khole VV. Naturally occurring anti-albumin antibodies are responsible for false positivity in diagnosis of autoimmune premature ovarian failure. J Histochem Cytochem. 2006;54(4):397–405.
Gobert B, Barbarino-Monnier P, Guillet-May F, Béné MC, Faure G. Anti-ovary antibodies after attempts at human in-vitro fertilization induced by follicular puncture rather than hormonal stimulation. J Reprod Fertil. 1992;96:213–8.
Barbarino-Monnier P, Jouan C, Dubois M, Gobert B, Faure GC, Béné MC. Antiovarian antibodies and in vitro fertilization: cause or consequence? Gynécol Obstét Fertil. 2003;31:770–3.
Pires ES, Meherji PK, Vaidya RR, Parikh FR, Ghosalkar MN, Khole VV. Specific and sensitive immunoassays detect multiple anti-ovarian antibodies in women with infertility. J Histochem Cytochem. 2007;55(12):1181–90.
Pires ES and Khole VV: Anti-ovarian antibodies: Specificity, prevalence, multiple antigenicity and significance in human ovarian autoimmunity. Current Paradigm of Reproductive Immunology: ISBN: 978-81-308-0373-9. Research signpost, Trivandrum, India, 2009*, pp 159–190
Vallotton MB, Forbes AP. Antibodies to cytoplasm of ova. Lancet. 1996;2:264–5.
Damewood MD, Zacur HA, Hoffman GJ, Rock JA. Circulating antiovarian antibodies in premature ovarian failure. Obstet Gynecol. 1986;68:850–4.
Tong ZB, Nelson LM. A mouse gene encoding an oocyte antigen associated with autoimmune premature ovarian failure. Endocrinology. 1999;140:3720–6.
Pires ES, Khole VV. A block in the road to fertility: autoantibodies to heat-shock protein 90-beta in human ovarian autoimmunity. Fertil Steril. 2009;92(4):1395–409.
Shivers CA, Dunbar BS. Autoantibodies to zona pellucida: a possible cause for infertility in women. Science. 1977;197:1082–4.
Mori T, Nishimoto T, Kitagawa M, Noda Y, Nishimura T, Oikawa T. Possible presence of autoantibodies to zona pellucida in infertile women. Experientia. 1978;34:797–9.
Sacco AG, Moghissi KS. Anti-zona pellucida activity in human sera. Fertil Steril. 1979;31:503–6.
Kamada M, Daitoh T, Mori K, Maeda N, Hirano K, Irahara M, et al. Etiological implication of autoantibodies to zona pellucida in human female infertility. Am J Reprod Immunol. 1992;28:104–9.
Mantzavinos T, Dalamanga N, Hassiakos D, Dimitriadou F, Konidaris S, Zourlas PA. Assessment of autoantibodies to the zona pellucida in serum and follicular fluid in in-vitro fertilization patients. Clin Exp Obstet Gynecol. 1993;20:111–5.
Papale ML, Grillo A, Leonardi E, Giuffrida G, Palumbo M, Palumbo G. Assessment of the relevance of zona pellucida antibodies in follicular fluid of in-vitro fertilization (IVF) patients. Hum Reprod. 1994;9:1827–31.
Kelkar RL, Meherji PK, Kadam SS, Gupta SK, Nandedkar TD. Circulating auto-antibodies against the zona pellucida and thyroid microsomal antigen in women with premature ovarian failure. J Reprd Immunol. 2005;66(1):53–67.
Anderson JR, Goudie RB. Gray KG and Stuart Smith DA: Immunological features of idiopathic Addison’s disease: an antibody to cells producing steroid hormones. Clin Exp Immunol. 1968;3:107–10.
Irvine WJ, Chan MMW, Scarth L, Hartog M, Bayliss RIS, Drury MI. Immunological aspects of premature ovarian failure associated with idiopathic Addison’s disease. Lancet. 1968;2:883–7.
Falorni A, Laureti S, Candeloro P, Perrino S, Coronella C, Bizzarro A, et al. Steroid-cell autoantibodies are preferentially expressed in women with premature ovarian failure who have adrenal autoimmunity. Fertil Steril. 2002;78:270–9.
Arif S, Vallian S, Farzaneh F, Zanone MM, James SL, Pietropaolo M, et al. Identification of 3β-hydroxysteroid dehydrogenase as a novel target of steroid cell antibodies: association of autoantibodies with endocrine autoimmune disease. J Clin Endocrinol Metab. 1996;81:4439–45.
Pasoto SG, Viana VS, Mendonca BB, Yoshinari NH, Bonfa E. Anti-corpus luteum antibody: a novel serological marker for ovarian dysfunction in systemic lupus erythematosus? J Rheumatol. 1999;26:1087–93.
Winqvist O, Gebre-Medhin G, Gustafsson J, Ritzen EM, Lundkvist O, Karlsson FA, et al. Identification of the main gonadal autoantigens in patients with adrenal insufficiency and associated ovarian failure. J Clin Endocrinol Metab. 1995;80:1717–23.
Platia MP, Bloomquist G, Williams RF, Hodgen GD. Refractoriness to gonadotropin therapy: how to distinguish ovarian failure versus pseudoovarian resistance caused by neutralizing antibodies. Fertil Steril. 1984;42:779–84.
Meyer WR, Lavy G, DeCherney AH, Visintin I, Economy K, Luborsky JL. Evidence of gonadal and gonadotropin antibodies in women with a suboptimal ovarian response to exogenous gonadotropin. Obstet Gynecol. 1990;75:795–9.
Gobert B, Jolivet-Reynaud C, Dalbon P, Barbarino-Monnier P, Faure G, Jolivet M, et al. An immunoreactive peptide of the FSH involved in autoimmune infertility. Biochem Biophys Res Commun. 2001;289:819–24.
Sundblad V, Bussmann L, Chiauzzi VA, Pancholi V, Charreau EH. α-enolase: a novel autoantigen in patients with premature ovarian failure. Clin Endocrinol. 2006;65:745–51.
Author information
Authors and Affiliations
Corresponding author
Additional information
Capsule
Multiple auto-antigens identified by anti-ovarian antibodies are involved in ovarian autoimmunity which could result in ovarian insufficiency and thereby failure to perform its normal reproductive function.
Rights and permissions
About this article
Cite this article
Pires, E.S. Multiplicity of molecular and cellular targets in human ovarian autoimmunity: an update. J Assist Reprod Genet 27, 519–524 (2010). https://doi.org/10.1007/s10815-010-9440-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10815-010-9440-5